Skip to main content

Table 3 Variables’ descriptors and hierarchical levels

From: Effectiveness of pharmaceutical care for drug treatment adherence in patients with systemic lupus erythematosus in Rio de Janeiro, Brazil: study protocol for a randomized controlled trial

Proximal

Intermediate

Distal

Lupus-related

Medical follow-up

Demographic, social and economic characteristics

 Age at onset of symptoms

 

Schooling

 Age at diagnosis

Missing scheduled appointment

Age

 Disease duration

 

Marital status

 Number of hospital admissions

 

Ethnicity

  

Paid occupation

Clinical manifestations

 

Lupus as the cause of impairment

 SELENA-SLEDAI

 

Total family income

 Total score

 

Per capita family income

Drug therapy

 

Number of household individuals

 Description

 

Drug disposal

 Pharmacological group

 

Family support

 Number of drugs

 

Individual patient-related factors

 Dosage/day

 

Disease knowledge

  

Symptoms

Over-the-counter (OTC) medicines

 

Chronicity

Drug-related adverse events

 

Treatment

 Attitude toward side effects

 

Food habits

  

Number of meals a day

  

Food restriction or diet

  

Alcohol intake

  

Smoking

  

Frequency (cigarettes/day)

  

Years of smoking

  

Physical activity

  

Description

  

Frequency (days/week)

  1. SELENA-SLEDAI Safety of Estrogens in Lupus Erythematosus National Assessment/Systemic Lupus Erythematosus Disease Activity Index